Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results BOSTON, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter and fiscal year ended December 31, 2025. Recent Highlights: Fourth quarter 2025 revenue from Continuing Operations of $23.8 million; Full Year 2025 revenue of $85.3 millionFully operationalized over $40 million in previously announced annualized cost savings supporting path to positive adjusted EBITDA and adjusted cash flow exiting 2026Ap...
Rapid7 to Attend Raymond James 47th Annual Institutional Investors Conference BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, today announced that the company will be attending the Raymond James 47th Annual Institutional Investors Conference. The presentation is scheduled for Wednesday, March 4, 2026 at 11:35 a.m. Eastern Time. The presentation will be webcast live, and a replay will be available for a limited time, under the “Events and Presentations” section on the company’s investor relations website at . About...
Rapid7 Announces 2026 Partner of the Year Award Winners BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, today announced the winners of its 2026 Partner of the Year Awards. The annual awards program recognizes and honors partners around the globe for excellence in helping customers evolve their security programs to reduce risk earlier, operate more efficiently, and build lasting cyber resilience. “Our partners play a critical role in helping customers shift from reactive security to a more preemptive, outcomes-drive...
Rapid7 Announces Fourth Quarter and Full-Year 2025 Financial Results Annualized recurring revenue (“ARR”) of $840 millionFull-year revenue of $860 million, increased 2% year-over-yearFull-year net cash provided by operating activities of $154 million; free cash flow of $130 million BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- . (Nasdaq: RPD), a global leader in AI-powered managed cybersecurity operations, today announced its financial results for the fourth quarter and full year 2025. "Rapid7 exited 2025 delivering outperformance against fourth quarter ARR, revenue, and profitability g...
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 BOSTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, after U.S. market close. About Standard BioTools Inc. Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop better medicines faster. As a leading solutions provider, the comp...
Standard BioTools Completes Sale of SomaLogic to Illumina Received $350 Million in upfront cash at closing; Up to $425 Million in total proceeds inclusive of near-term earnout payments Approximately $550 Million in cash & cash equivalents on balance sheet at close, excluding potential future earnouts, to fuel inorganic growth strategy Continuing Operations on track to achieve positive adjusted EBITDA in 2026 BOSTON, Mass., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced it has completed the previously announ...
Rapid7 to Report Fourth Quarter and Full Year 2025 Financial Results on February 10 BOSTON, Jan. 15, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RPD), a leader in threat detection and exposure management, today announced that the company will release its fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026, after the financial markets close. The company will host a conference call that same day to discuss its results and business outlook at 4:30 p.m. Eastern Time. To register for the live event please visit: . A live webcast of the conference call and the financial r...
Rapid7 and ARMO Enable Organizations to Stop Cloud Attacks Earlier with Runtime Security New runtime security capabilities reduce cloud risk faster and help security teams respond to active threats with confidence BOSTON, Jan. 14, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RPD), a leader in threat detection and exposure management, announced a strategic partnership with , the creators of the open-source cloud-native security platform Kubescape and Cloud Application Detection & Response (CADR) innovator, to bring full cloud and application runtime security to the Rapid7 Command Platform. This m...
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Preliminary, unaudited combined company revenue for the full year 2025 of approximately $185 million; Revenue from continuing operations of approximately $85 million BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced preliminary and unaudited revenue results for the fourth quarter and full year 2025. Standard BioTools expects fourth quarter 2025 combined company revenue of approximately $56 million and revenue from continuin...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.